Company / Working Capital
ANAPTYSBIO, INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$311.6M
FY2025
5-year range
$311.6M / $537.8M
FY2021-FY2025
Trend
-19.4%
vs FY2024
Sector context
#136 of 213
Health Care
What the data says
At $312M, ANAPTYSBIO, INC's working capital ranks #136 of 213 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $53M in FY2016 to $538M in FY2021.
Based on SEC 10-K filings.
$312M in FY2025 with a 5-year CAGR of -3.7%.
Declined from $369M to $312M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -9.6%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
#136 of 213 in Health CareTop 64% of 213This company $311.6M Sector average $934.6M
▼
-66.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.7%, indicating a declining trend.
- In FY2025, working capital decreased 19.4% year-over-year.
- Ranks #136 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $311.6M | -19.4% |
| FY2024 | $386.4M | +4.6% |
| FY2023 | $369.4M | -12.3% |
| FY2022 | $421.2M | -21.7% |
| FY2021 | $537.8M | +42.7% |
| FY2020 | $376.7M | +8.2% |
| FY2019 | $348.2M | -15.6% |
| FY2018 | $412.4M | +72.8% |
| FY2017 | $238.6M | +354.5% |
| FY2016 | $52.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026